Health Trials

Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS Technique

ConditionsNd:YAG LaserSclerotherapyDiode LaserReticular VeinsTelangiectasiasCLaCS Technique
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorAin Shams University

About this trial

This study aims to compare the efficacy (in terms of vein clearance) and safety of Nd:YAG laser combined with injection sclerotherapy versus diode laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias using the Cryo-Laser and Cryo-Sclerotherapy (CLaCS) technique.

Eligibility criteria

Qualifiers

Patients aged 18-60 years.

Both sexes.

Presence of reticular veins and/or telangiectasias (CEAP classification C1).

Fitzpatrick skin types II-V.

Disqualifiers

Pregnancy or lactation.

History of deep vein thrombosis.

Coagulation disorders.

Allergy to sclerosant agents.

Trial design

Treatments tested in this trial

  • Nd:YAG laser
  • Diode laser

Treatment groups

80 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ain Shams University

Lead sponsor

Source ClinicalTrials.gov